GB9818914D0 - Use - Google Patents

Use

Info

Publication number
GB9818914D0
GB9818914D0 GBGB9818914.5A GB9818914A GB9818914D0 GB 9818914 D0 GB9818914 D0 GB 9818914D0 GB 9818914 A GB9818914 A GB 9818914A GB 9818914 D0 GB9818914 D0 GB 9818914D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818914.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9818914.5A priority Critical patent/GB9818914D0/en
Publication of GB9818914D0 publication Critical patent/GB9818914D0/en
Priority to PCT/EP1999/006219 priority patent/WO2000012623A2/fr
Priority to AU59706/99A priority patent/AU5970699A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
GBGB9818914.5A 1998-08-28 1998-08-28 Use Ceased GB9818914D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use
PCT/EP1999/006219 WO2000012623A2 (fr) 1998-08-28 1999-08-25 Utilisation
AU59706/99A AU5970699A (en) 1998-08-28 1999-08-25 Use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Publications (1)

Publication Number Publication Date
GB9818914D0 true GB9818914D0 (en) 1998-10-21

Family

ID=10838073

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818914.5A Ceased GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Country Status (3)

Country Link
AU (1) AU5970699A (fr)
GB (1) GB9818914D0 (fr)
WO (1) WO2000012623A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
PE20020063A1 (es) * 2000-06-20 2002-01-30 Upjohn Co Bis-arilsulfonas como ligandos del receptor de 5-ht
US6586592B2 (en) 2000-06-20 2003-07-01 Pharmacia & Upjohn Company Bis-arylsulfones
US7071220B2 (en) 2000-09-18 2006-07-04 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
CA2422807C (fr) * 2000-09-18 2009-12-08 Toa Eiyo Ltd. Derives de benzothiophenesulfonamide substitue en n
IL156602A0 (en) 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic chromone compounds
AU2002217742B2 (en) 2001-01-16 2008-02-21 Astrazeneca Ab Therapeutic heterocyclic compounds
US7718650B2 (en) 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
MXPA03010232A (es) * 2001-05-11 2004-03-16 Biovitrum Ab Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
EP1423106B1 (fr) 2001-08-10 2008-12-17 F. Hoffmann-La Roche Ag Derives d'arylsulfonyle avec affinite pour le recepteur 5-ht 6
DE60333351D1 (de) * 2002-03-15 2010-08-26 Toa Eiyo Ltd N-substituiertes benzothiophensulfonamidderivat
PA8802201A1 (es) * 2007-11-02 2009-06-23 Abbott Gmbh & Co Kg Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
TWI465449B (zh) 2008-10-23 2014-12-21 Vertex Pharma 囊腫性纖維化跨膜傳導調節因子之調控因子
JP2012525355A (ja) 2009-04-30 2012-10-22 アボット ゲーエムベーハー ウント カンパニー カーゲー セロトニン５−ｈｔ６受容体の調節に応答する障害を治療するのに適したベンゼンスルホンアニリド化合物
KR20120016639A (ko) 2009-04-30 2012-02-24 애보트 게엠베하 운트 콤파니 카게 세로토닌 5-ｈｔ6 수용체의 조절에 반응하는 장애를 치료하는 데 적합한 ｎ-페닐-(피페라지닐 또는 호모피페라지닐)-벤젠설폰아미드 또는 벤젠설포닐-페닐-(피페라진 또는 호모피페라진) 화합물
US8343959B2 (en) 2009-04-30 2013-01-01 Abbott Gmbh & Co. Kg N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
MX2011011515A (es) 2009-04-30 2012-01-30 Abbott Gmbh & Co Kg Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
WO2012059432A1 (fr) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Composés de type n-phényl-(homo)pipérazinyl-benzènesulfonyle ou benzènesulfonamide appropriés pour le traitement de troubles qui répondent à la modulation du récepteur 5-ht6
WO2012059431A1 (fr) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Composés de type benzènesulfonyle ou sulfonamide appropriés pour le traitement de troubles qui répondent à la modulation du récepteur 5-ht6 de la sérotonine
WO2015061515A1 (fr) * 2013-10-25 2015-04-30 Glaxosmithkline Llc Nouveaux composés
MX2018013031A (es) * 2016-04-26 2019-01-17 H Lundbeck As Uso de un inhibidor de la acetilcolinesterasa e idalopirdina para reducir las caidas en pacientes con la enfermedad de parkinson.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
NZ501258A (en) * 1997-07-11 2001-07-27 Smithkline Beecham P Benzenesulfonamide compounds with 5HT6 receptor antagonist activity for treating anxiety and/or depression
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO2000012623A3 (fr) 2000-08-24
WO2000012623A2 (fr) 2000-03-09
AU5970699A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
IL139145A0 (en) New use
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69914921D1 (en) Phenyl-xanthinderivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE69940558D1 (en) Fluoromonomerpolymerisation
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
GB9818914D0 (en) Use
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
GB9814640D0 (en) New use
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69938146D1 (en) Ptc-chip-thermistor
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69905001D1 (en) Koagulationsvorrichtung
DE69904442D1 (en) Cyclohexandiol-derivate
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
DE59904407D1 (en) Chromanderivate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)